For information about COVID-19, including symptoms and prevention, please read our COVID-19 patient guide. If you need to see your provider, please contact us to see if a Video Visit is right for you. Please also consider supporting Weill Cornell Medicine’s efforts against the pandemic.
Menu
Department of Anesthesiology

You are here

Home > Publications

Publications

Author Title Type [ Year(Asc)]
Filters: Author is Ali, H H  [Clear All Filters]
1990
Dresner DL, Basta SJ, Ali HH, Schwartz AF, Embree PB, Wargin WA, Lai AA, Brady KA, Savarese JJ.  1990.  Pharmacokinetics and pharmacodynamics of doxacurium in young and elderly patients during isoflurane anesthesia.. Anesth Analg. 71(5):498-502.
1989
Savarese JJ, Ali HH, Basta SJ, Scott RP, Embree PB, Wastila WB, Abou-Donia MM, Gelb C.  1989.  The cardiovascular effects of mivacurium chloride (BW B1090U) in patients receiving nitrous oxide-opiate-barbiturate anesthesia.. Anesthesiology. 70(3):386-94.
1988
Savarese JJ, Ali HH, Basta SJ, Embree PB, Scott RP, Sunder N, Weakly JN, Wastila WB, el-Sayad HA.  1988.  The clinical neuromuscular pharmacology of mivacurium chloride (BW B1090U). A short-acting nondepolarizing ester neuromuscular blocking drug.. Anesthesiology. 68(5):723-32.
Basta SJ, Savarese JJ, Ali HH, Embree PB, Schwartz AF, Rudd GD, Wastila WB.  1988.  Clinical pharmacology of doxacurium chloride. A new long-acting nondepolarizing muscle relaxant.. Anesthesiology. 69(4):478-86.
Ali HH, Savarese JJ, Embree PB, Basta SJ, Stout RG, Bottros LH, Weakly JN.  1988.  Clinical pharmacology of mivacurium chloride (BW B1090U) infusion: comparison with vecuronium and atracurium.. Br J Anaesth. 61(5):541-6.
Goldhill DR, Embree PB, Ali HH, Savarese JJ.  1988.  Reversal of pancuronium. Neuromuscular and cardiovascular effects of a mixture of neostigmine and glycopyrronium.. Anaesthesia. 43(6):443-6.
1986
Scott RP, Savarese JJ, Basta SJ, Embree P, Ali HH, Sunder N, Hoaglin DC.  1986.  Clinical pharmacology of atracurium given in high dose.. Br J Anaesth. 58(8):834-8.
deBros FM, Lai A, Scott R, deBros J, Batson AG, Goudsouzian N, Ali HH, Cosimi AB, Savarese JJ.  1986.  Pharmacokinetics and pharmacodynamics of atracurium during isoflurane anesthesia in normal and anephric patients.. Anesth Analg. 65(7):743-6.
1985
Scott RP, Savarese JJ, Basta SJ, Sunder N, Ali HH, Gargarian M, Gionfriddo M, Batson AG.  1985.  Atracurium: clinical strategies for preventing histamine release and attenuating the haemodynamic response.. Br J Anaesth. 57(6):550-3.
1983
Savarese JJ, Ali HH, Basta SJ, Sunder N, Moss J, Gionfriddo MA, Lineberry CG, Wastila WB, el-Sayad HA, Montague D et al..  1983.  The clinical pharmacology of BW A444U. A nondepolarizing ester relaxant of intermediate duration.. Anesthesiology. 58(4):333-41.
Ali HH, Savarese JJ, Basta SJ, Sunder N, Gionfriddo M.  1983.  Evaluation of cumulative properties of three new nondepolarizing neuromuscular blocking drugs BW A444U, atracurium and vecuronium.. Br J Anaesth. 55 Suppl 1:107S-111S.
Basta SJ, Savarese JJ, Ali HH, Moss J, Gionfriddo M.  1983.  Histamine-releasing potencies of atracurium, dimethyl tubocurarine and tubocurarine.. Br J Anaesth. 55 Suppl 1:105S-106S.
1982
Basta SJ, Ali HH, Savarese JJ, Sunder N, Gionfriddo M, Cloutier G, Lineberry C, Cato AE.  1982.  Clinical pharmacology of atracurium besylate (BW 33A): a new non-depolarizing muscle relaxant.. Anesth Analg. 61(9):723-9.
1981
Lebowitz PW, Ramsey FM, Savarese JJ, Ali HH, deBros FM.  1981.  Combination of pancuronium and metocurine: neuromuscular and hemodynamic advantages over pancuronium alone.. Anesth Analg. 60(1):12-7.
Ali HH, Savarese JJ, Lebowitz PW, Ramsey FM.  1981.  Twitch, tetanus and train-of-four as indices of recovery from nondepolarizing neuromuscular blockade.. Anesthesiology. 54(4):294-7.
1980
Ramsey FM, Lebowitz PW, Savarese JJ, Ali HH.  1980.  Clinical characteristics of long-term succinylcholine neuromuscular blockade during balanced anesthesia.. Anesth Analg. 59(2):110-6.
Donlon JV, Savarese JJ, Ali HH, Teplik RS.  1980.  Human dose-response curves for neuromuscular blocking drugs: a comparison of two methods of construction and analysis.. Anesthesiology. 53(2):161-6.
Martyn JA, Szyfelbein SK, Ali HH, Matteo RS, Savarese JJ.  1980.  Increased d-tubocurarine requirement following major thermal injury.. Anesthesiology. 52(4):352-5.
Lebowitz PW, Ramsey FM, Savarese JJ, Ali HH.  1980.  Potentiation of neuromuscular blockade in man produced by combinations of pancuronium and metocurine or pancuronium and d-tubocurarine.. Anesth Analg. 59(8):604-9.
Ali HH, Savarese JJ.  1980.  Stimulus frequency and dose-respone curve to d-tubocurarine in man.. Anesthesiology. 52(1):36-9.
1979
Donlon JV, Savarese JJ, Ali HH.  1979.  Cumulative dose-response curves for gallamine: effect of altered resting thumb tension and mode of stimulation.. Anesth Analg. 58(5):377-81.
Ali HH, Savarese JJ.  1979.  Stimulus frequency is essential information.. Anesthesiology. 50(1):76-7.
1978
Mitchell MM, Ali HH, Savarese JJ.  1978.  Myotonia and neuromuscular blocking agents.. Anesthesiology. 49(1):44-8.
1977
Savarese JJ, Ali HH, Antonio RP.  1977.  The clinical pharmacology of metocurine: dimethyltubocurarine revisited.. Anesthesiology. 47(3):277-84.
1976
Ali HH, Savarese JJ.  1976.  Monitoring of neuromuscular function.. Anesthesiology. 45(2):216-49.